The American Journal of dermatopathology · 2022
Squamoid Eccrine Ductal Carcinoma: Treatment and Outcomes.
Клинический случайСтатьяОбзорНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Lim Megan M, Macdonald Jillian A
Аннотация
BACKGROUND: Squamoid eccrine ductal carcinoma (SEDC) represents a subtype of eccrine carcinomas that are diagnostically challenging for both clinicians and dermatopathologists.
OBJECTIVE: To provide an updated review of SEDC and examine patient outcomes with different treatment modalities.
METHODS: A review of Ovid MEDLINE was performed to review the English language medical literature of SEDC.
RESULTS: A comprehensive review of clinical presentation, histologic findings, rates of lymphovascular and metastatic disease, treatment modalities and recurrence rates are reviewed.
LIMITATIONS: There is a limitation on available data because of the rare incidence.
CONCLUSIONS: SEDC is a rare adnexal neoplasm with a relatively high rate of local recurrence, lymphovascular invasion, perineural invasion, and metastases. Clinicians should be aware of this entity as close follow-up is essential to detect recurrence and metastatic disease. Mohs micrographic surgery seems to result in superior patient outcomes.
OBJECTIVE: To provide an updated review of SEDC and examine patient outcomes with different treatment modalities.
METHODS: A review of Ovid MEDLINE was performed to review the English language medical literature of SEDC.
RESULTS: A comprehensive review of clinical presentation, histologic findings, rates of lymphovascular and metastatic disease, treatment modalities and recurrence rates are reviewed.
LIMITATIONS: There is a limitation on available data because of the rare incidence.
CONCLUSIONS: SEDC is a rare adnexal neoplasm with a relatively high rate of local recurrence, lymphovascular invasion, perineural invasion, and metastases. Clinicians should be aware of this entity as close follow-up is essential to detect recurrence and metastatic disease. Mohs micrographic surgery seems to result in superior patient outcomes.